Caroline M Mitchell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagina | 58 | 2025 | 849 | 14.320 |
Why?
|
Vaginosis, Bacterial | 27 | 2025 | 154 | 8.870 |
Why?
|
Postmenopause | 23 | 2024 | 2517 | 5.660 |
Why?
|
Lactobacillus | 25 | 2024 | 212 | 5.530 |
Why?
|
Vaginal Diseases | 14 | 2023 | 103 | 5.270 |
Why?
|
Estradiol | 13 | 2024 | 1947 | 2.830 |
Why?
|
Menopause | 15 | 2024 | 1657 | 2.750 |
Why?
|
Cervix Uteri | 8 | 2021 | 575 | 2.080 |
Why?
|
Estrogens | 11 | 2023 | 1528 | 1.910 |
Why?
|
Pelvic Inflammatory Disease | 3 | 2021 | 95 | 1.870 |
Why?
|
Vaginal Creams, Foams, and Jellies | 6 | 2022 | 62 | 1.810 |
Why?
|
Vaginitis | 3 | 2024 | 50 | 1.770 |
Why?
|
RNA, Ribosomal, 16S | 11 | 2024 | 1044 | 1.480 |
Why?
|
Metronidazole | 9 | 2025 | 237 | 1.400 |
Why?
|
Female Urogenital Diseases | 3 | 2024 | 57 | 1.370 |
Why?
|
Gardnerella vaginalis | 5 | 2016 | 20 | 1.190 |
Why?
|
Lasers, Gas | 2 | 2020 | 104 | 1.150 |
Why?
|
Vulvar Diseases | 5 | 2020 | 64 | 1.120 |
Why?
|
Vaginal Douching | 5 | 2021 | 17 | 1.070 |
Why?
|
Probiotics | 3 | 2020 | 387 | 1.070 |
Why?
|
HIV-1 | 12 | 2020 | 6948 | 1.050 |
Why?
|
Virus Shedding | 4 | 2020 | 110 | 0.980 |
Why?
|
Escherichia coli | 4 | 2021 | 4211 | 0.980 |
Why?
|
Premenopause | 3 | 2021 | 1039 | 0.980 |
Why?
|
Estrone | 3 | 2022 | 234 | 0.950 |
Why?
|
Vaginal Discharge | 3 | 2021 | 25 | 0.940 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2024 | 25 | 0.930 |
Why?
|
Pelvic Organ Prolapse | 1 | 2024 | 116 | 0.830 |
Why?
|
Dyspareunia | 3 | 2019 | 48 | 0.820 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2021 | 2478 | 0.810 |
Why?
|
Cytokines | 8 | 2025 | 7438 | 0.810 |
Why?
|
Glycogen | 4 | 2023 | 252 | 0.800 |
Why?
|
Vulva | 2 | 2023 | 84 | 0.800 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2023 | 2429 | 0.790 |
Why?
|
Urinary Incontinence | 2 | 2023 | 490 | 0.760 |
Why?
|
Sexual Behavior | 6 | 2022 | 2192 | 0.760 |
Why?
|
Hydrogen Peroxide | 3 | 2015 | 740 | 0.760 |
Why?
|
Carrier State | 2 | 2015 | 530 | 0.740 |
Why?
|
Female | 100 | 2025 | 396520 | 0.740 |
Why?
|
Chlamydia Infections | 2 | 2021 | 365 | 0.720 |
Why?
|
Estrogen Replacement Therapy | 4 | 2022 | 1205 | 0.710 |
Why?
|
Bacteroides | 1 | 2020 | 165 | 0.700 |
Why?
|
Lubricants | 1 | 2020 | 26 | 0.700 |
Why?
|
HIV Infections | 15 | 2021 | 17536 | 0.690 |
Why?
|
Sexually Transmitted Diseases | 3 | 2022 | 668 | 0.690 |
Why?
|
Administration, Intravaginal | 6 | 2021 | 149 | 0.690 |
Why?
|
Urinary Tract Infections | 3 | 2021 | 804 | 0.680 |
Why?
|
Gonorrhea | 2 | 2021 | 355 | 0.680 |
Why?
|
RNA, Viral | 6 | 2020 | 2867 | 0.670 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2015 | 2184 | 0.670 |
Why?
|
DNA, Viral | 4 | 2020 | 2201 | 0.670 |
Why?
|
Urinary Tract | 1 | 2023 | 305 | 0.660 |
Why?
|
Sexual Dysfunctions, Psychological | 3 | 2022 | 193 | 0.660 |
Why?
|
Atrophy | 6 | 2023 | 1631 | 0.660 |
Why?
|
Mucus | 1 | 2021 | 346 | 0.650 |
Why?
|
Epithelium | 2 | 2021 | 1606 | 0.630 |
Why?
|
Genital Diseases, Female | 1 | 2018 | 192 | 0.560 |
Why?
|
Inflammation | 8 | 2024 | 10860 | 0.560 |
Why?
|
Bodily Secretions | 2 | 2020 | 28 | 0.540 |
Why?
|
Escherichia coli Infections | 1 | 2020 | 518 | 0.530 |
Why?
|
Vulvovaginitis | 1 | 2016 | 14 | 0.520 |
Why?
|
Humans | 102 | 2025 | 766766 | 0.510 |
Why?
|
Bacteria | 7 | 2023 | 2212 | 0.500 |
Why?
|
Interleukin-8 | 3 | 2021 | 702 | 0.480 |
Why?
|
Fibroblasts | 1 | 2024 | 4166 | 0.450 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.430 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2014 | 153 | 0.430 |
Why?
|
alpha-Defensins | 1 | 2012 | 30 | 0.420 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 235 | 0.410 |
Why?
|
beta-Defensins | 1 | 2012 | 59 | 0.410 |
Why?
|
Endometrium | 1 | 2014 | 406 | 0.390 |
Why?
|
Biofilms | 1 | 2016 | 641 | 0.380 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1920 | 0.380 |
Why?
|
Middle Aged | 34 | 2024 | 223257 | 0.370 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7475 | 0.360 |
Why?
|
Syndrome | 3 | 2023 | 3271 | 0.350 |
Why?
|
Anti-Retroviral Agents | 3 | 2015 | 1787 | 0.340 |
Why?
|
Premature Birth | 3 | 2021 | 1830 | 0.340 |
Why?
|
Desiccation | 1 | 2009 | 77 | 0.330 |
Why?
|
Chlamydia trachomatis | 2 | 2021 | 239 | 0.330 |
Why?
|
Women's Health | 2 | 2018 | 2081 | 0.320 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2254 | 0.320 |
Why?
|
Microbial Interactions | 2 | 2021 | 74 | 0.310 |
Why?
|
Cesarean Section | 4 | 2023 | 1418 | 0.310 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1466 | 0.290 |
Why?
|
Adult | 34 | 2025 | 223307 | 0.290 |
Why?
|
Young Adult | 19 | 2025 | 59939 | 0.290 |
Why?
|
HIV Seronegativity | 1 | 2008 | 209 | 0.280 |
Why?
|
Clomiphene | 1 | 2007 | 71 | 0.280 |
Why?
|
False Positive Reactions | 1 | 2009 | 957 | 0.280 |
Why?
|
Blood | 1 | 2009 | 597 | 0.280 |
Why?
|
Pregnancy | 16 | 2023 | 30237 | 0.270 |
Why?
|
Fertility Agents, Female | 1 | 2007 | 101 | 0.270 |
Why?
|
Interleukin-1beta | 2 | 2013 | 1026 | 0.260 |
Why?
|
Viral Load | 3 | 2020 | 3385 | 0.260 |
Why?
|
Pregnancy Trimester, First | 2 | 2009 | 917 | 0.250 |
Why?
|
Hot Flashes | 3 | 2020 | 329 | 0.250 |
Why?
|
Polymerase Chain Reaction | 6 | 2012 | 6066 | 0.240 |
Why?
|
Interleukin-6 | 2 | 2021 | 3227 | 0.240 |
Why?
|
Tablets | 2 | 2022 | 149 | 0.240 |
Why?
|
Specimen Handling | 1 | 2009 | 706 | 0.240 |
Why?
|
Metabolome | 2 | 2022 | 1009 | 0.230 |
Why?
|
Double-Blind Method | 6 | 2022 | 12430 | 0.230 |
Why?
|
Amylases | 1 | 2023 | 171 | 0.210 |
Why?
|
Carbolines | 1 | 2024 | 288 | 0.200 |
Why?
|
Acetic Acid | 1 | 2021 | 58 | 0.190 |
Why?
|
Aged | 14 | 2024 | 171343 | 0.190 |
Why?
|
Prospective Studies | 16 | 2025 | 54871 | 0.190 |
Why?
|
Mycoplasma genitalium | 1 | 2021 | 13 | 0.190 |
Why?
|
Sodium Bicarbonate | 1 | 2021 | 60 | 0.190 |
Why?
|
Immunity, Mucosal | 2 | 2016 | 498 | 0.190 |
Why?
|
Glycerol | 1 | 2022 | 274 | 0.190 |
Why?
|
Mycoplasma Infections | 1 | 2021 | 120 | 0.180 |
Why?
|
Minnesota | 1 | 2021 | 339 | 0.180 |
Why?
|
Infertility, Female | 1 | 2007 | 763 | 0.180 |
Why?
|
Vaginal Smears | 2 | 2015 | 505 | 0.180 |
Why?
|
Quality of Life | 8 | 2024 | 13476 | 0.180 |
Why?
|
Mucous Membrane | 2 | 2014 | 658 | 0.180 |
Why?
|
Bacteriological Techniques | 2 | 2020 | 277 | 0.180 |
Why?
|
Aging | 2 | 2019 | 8731 | 0.180 |
Why?
|
Electronic Mail | 1 | 2022 | 215 | 0.180 |
Why?
|
Suburethral Slings | 1 | 2021 | 69 | 0.170 |
Why?
|
Models, Biological | 1 | 2016 | 9461 | 0.170 |
Why?
|
Ceftriaxone | 1 | 2021 | 176 | 0.170 |
Why?
|
Dysmenorrhea | 1 | 2021 | 104 | 0.170 |
Why?
|
Kenya | 2 | 2013 | 759 | 0.170 |
Why?
|
Pruritus | 1 | 2023 | 378 | 0.170 |
Why?
|
Adolescent | 15 | 2021 | 88904 | 0.170 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 2 | 2010 | 23 | 0.170 |
Why?
|
Personality | 1 | 2023 | 560 | 0.160 |
Why?
|
Iodine | 1 | 2021 | 285 | 0.160 |
Why?
|
Antifungal Agents | 1 | 2024 | 769 | 0.160 |
Why?
|
Doxycycline | 1 | 2021 | 348 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 236 | 0.160 |
Why?
|
Bacterial Adhesion | 1 | 2020 | 306 | 0.160 |
Why?
|
Neisseria gonorrhoeae | 1 | 2021 | 249 | 0.150 |
Why?
|
Prevotella | 2 | 2017 | 81 | 0.150 |
Why?
|
Fecal Incontinence | 1 | 2021 | 246 | 0.150 |
Why?
|
Estriol | 1 | 2018 | 53 | 0.150 |
Why?
|
Herpes Genitalis | 2 | 2024 | 148 | 0.150 |
Why?
|
Mucins | 1 | 2021 | 569 | 0.150 |
Why?
|
Coculture Techniques | 1 | 2021 | 1337 | 0.150 |
Why?
|
Gynecology | 1 | 2023 | 534 | 0.140 |
Why?
|
Gels | 1 | 2018 | 420 | 0.140 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2019 | 231 | 0.140 |
Why?
|
Delivery, Obstetric | 2 | 2021 | 949 | 0.140 |
Why?
|
Urinary Bladder | 1 | 2023 | 1155 | 0.140 |
Why?
|
Fatty Acids | 1 | 2024 | 1806 | 0.130 |
Why?
|
Obstetrics | 1 | 2023 | 679 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2023 | 14762 | 0.130 |
Why?
|
Immune System | 1 | 2021 | 800 | 0.130 |
Why?
|
Cohort Studies | 8 | 2019 | 41710 | 0.130 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 240 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10384 | 0.120 |
Why?
|
Prevalence | 4 | 2019 | 15835 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2039 | 0.120 |
Why?
|
Megasphaera | 1 | 2014 | 2 | 0.120 |
Why?
|
Leptotrichia | 1 | 2014 | 13 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1972 | 0.120 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2018 | 490 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1805 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15908 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2021 | 65273 | 0.120 |
Why?
|
Placebo Effect | 1 | 2018 | 515 | 0.120 |
Why?
|
Actinobacteria | 1 | 2014 | 62 | 0.120 |
Why?
|
Molecular Typing | 1 | 2014 | 115 | 0.110 |
Why?
|
Cyclohexanols | 1 | 2014 | 126 | 0.110 |
Why?
|
Uterine Diseases | 1 | 2014 | 108 | 0.110 |
Why?
|
Washington | 2 | 2012 | 315 | 0.110 |
Why?
|
Drug Implants | 1 | 2014 | 230 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3804 | 0.110 |
Why?
|
Uterine Cervicitis | 1 | 2013 | 31 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2024 | 364 | 0.110 |
Why?
|
DNA, Bacterial | 3 | 2012 | 1477 | 0.100 |
Why?
|
Cell Survival | 1 | 2021 | 5748 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 946 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1675 | 0.090 |
Why?
|
Administration, Oral | 2 | 2009 | 4018 | 0.090 |
Why?
|
Microfluidics | 1 | 2016 | 650 | 0.090 |
Why?
|
Bacterial Load | 1 | 2011 | 155 | 0.090 |
Why?
|
Body Fluids | 1 | 2012 | 321 | 0.090 |
Why?
|
Cervix Mucus | 1 | 2010 | 18 | 0.090 |
Why?
|
Affect | 1 | 2018 | 1494 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2016 | 865 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1120 | 0.080 |
Why?
|
Homosexuality, Female | 1 | 2011 | 171 | 0.080 |
Why?
|
Culture Media | 1 | 2011 | 893 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9602 | 0.080 |
Why?
|
Self Report | 2 | 2019 | 3771 | 0.080 |
Why?
|
Cytoplasm | 1 | 2014 | 1505 | 0.080 |
Why?
|
Hysterectomy | 1 | 2014 | 863 | 0.080 |
Why?
|
Regression Analysis | 2 | 2009 | 6329 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2013 | 1251 | 0.080 |
Why?
|
Infant | 4 | 2023 | 36461 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1186 | 0.080 |
Why?
|
Pregnancy in Adolescence | 1 | 2010 | 164 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 326 | 0.080 |
Why?
|
United States | 7 | 2022 | 72951 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3450 | 0.070 |
Why?
|
Fungi | 1 | 2010 | 346 | 0.070 |
Why?
|
Gestational Age | 3 | 2012 | 3617 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2446 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1852 | 0.070 |
Why?
|
Massachusetts | 2 | 2019 | 8891 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3989 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3429 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2586 | 0.070 |
Why?
|
Menstrual Cycle | 1 | 2010 | 539 | 0.070 |
Why?
|
Clothing | 1 | 2007 | 95 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26310 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 838 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3432 | 0.060 |
Why?
|
Vacuum Curettage | 2 | 2002 | 44 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1536 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2007 | 527 | 0.060 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.060 |
Why?
|
Interleukins | 1 | 2010 | 795 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1390 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2009 | 14652 | 0.060 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 987 | 0.060 |
Why?
|
Oleic Acid | 1 | 2024 | 89 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4562 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3691 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6207 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2846 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16724 | 0.050 |
Why?
|
Public Health | 1 | 2016 | 2681 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18397 | 0.050 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2022 | 52 | 0.050 |
Why?
|
Abortion, Incomplete | 1 | 2002 | 13 | 0.050 |
Why?
|
Recurrence | 2 | 2012 | 8507 | 0.050 |
Why?
|
Prenatal Care | 1 | 2010 | 1158 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5887 | 0.050 |
Why?
|
Mothers | 2 | 2023 | 2208 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18330 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59550 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22248 | 0.050 |
Why?
|
Genes, pol | 1 | 2020 | 53 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2016 | 18984 | 0.040 |
Why?
|
Genes, env | 1 | 2020 | 96 | 0.040 |
Why?
|
Abortion, Legal | 1 | 2002 | 121 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2021 | 26389 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 418 | 0.040 |
Why?
|
Menstruation | 1 | 2021 | 310 | 0.040 |
Why?
|
DNA, Ribosomal | 2 | 2012 | 300 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2020 | 297 | 0.040 |
Why?
|
Urinary Incontinence, Stress | 1 | 2021 | 180 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 40149 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15831 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2021 | 315 | 0.040 |
Why?
|
Attitude to Health | 1 | 2007 | 2021 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 228 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 960 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39309 | 0.040 |
Why?
|
Semen | 1 | 2020 | 349 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2007 | 1349 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 614 | 0.030 |
Why?
|
Cysteine | 1 | 2022 | 896 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 71 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 81635 | 0.030 |
Why?
|
Risk Factors | 3 | 2022 | 74881 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2002 | 471 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 472 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2493 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1505 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 42577 | 0.030 |
Why?
|
Rectum | 1 | 2020 | 896 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4056 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1121 | 0.030 |
Why?
|
Body Image | 1 | 2019 | 645 | 0.030 |
Why?
|
Orgasm | 1 | 2014 | 62 | 0.030 |
Why?
|
Breast Feeding | 1 | 2022 | 1363 | 0.030 |
Why?
|
Child | 2 | 2021 | 80668 | 0.030 |
Why?
|
Self Concept | 1 | 2019 | 1040 | 0.030 |
Why?
|
Perimenopause | 1 | 2014 | 142 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2457 | 0.030 |
Why?
|
Peru | 1 | 2015 | 888 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168930 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2565 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12985 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3208 | 0.020 |
Why?
|
South Africa | 1 | 2017 | 1875 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3833 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1104 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2429 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4780 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8728 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2758 | 0.020 |
Why?
|
Africa, Eastern | 1 | 2007 | 76 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12064 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6608 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5890 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22352 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2476 | 0.010 |
Why?
|
Registries | 1 | 2021 | 8351 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6259 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2921 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4410 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81889 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2007 | 405 | 0.010 |
Why?
|
Logistic Models | 2 | 2010 | 13278 | 0.010 |
Why?
|
Anxiety | 1 | 2018 | 4670 | 0.010 |
Why?
|
Abortion, Missed | 1 | 2002 | 11 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7431 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2010 | 1184 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10619 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23619 | 0.010 |
Why?
|
Health Education | 1 | 2007 | 1060 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2694 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2971 | 0.010 |
Why?
|
Family Planning Services | 1 | 2002 | 277 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8228 | 0.010 |
Why?
|
Pathology, Clinical | 1 | 2002 | 374 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9661 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3230 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4087 | 0.010 |
Why?
|
Vitamin D | 1 | 2007 | 3270 | 0.010 |
Why?
|
Health Surveys | 1 | 2002 | 4055 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21525 | 0.010 |
Why?
|
Male | 2 | 2020 | 364142 | 0.010 |
Why?
|
Health Care Costs | 1 | 2002 | 3242 | 0.000 |
Why?
|
Risk Assessment | 1 | 2010 | 24295 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15416 | 0.000 |
Why?
|